Neuronetics (STIM) Misses Q2 EPS by 6c ; Offers Guidance

Neuronetics (NASDAQ: STIM) reported Q2 EPS of ($0.33), $0.06 worse than the analyst estimate of ($0.27). Revenue for the quarter came in at $16.45 million versus the consensus estimate of $18.65 million.

GUIDANCE:

Neuronetics sees Q3 2024 revenue of $18.5-19.5 million, versus the consensus of $20.12 million.

Neuronetics sees FY2024 revenue of $78-80 million, versus the consensus of $79.14 million.

For earnings history and earnings-related data on Neuronetics (STIM) click here.

You May Also Be Interested In

• Movano (MOVE) Misses Q2 EPS by 195c
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
• Phillips 66, Marathon Merger Talks Collapsed - Semafor